You are here

Home

Biblio

Author Title Type [ Year(Asc)]
Filters: Keyword is Genetic Predisposition to Disease  [Clear All Filters]
2021
Horimoto ARVR, Xue D, Thornton TA, Blue EE.  2021.  Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics.. Alzheimers Res Ther. 13(1):122.
Patel D, Zhang X, Farrell JJ, Chung J, Stein TD, Lunetta KL, Farrer LA.  2021.  Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue.. Transl Psychiatry. 11(1):250.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I et al..  2021.  Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.. Nat Commun. 12(1):3417.
Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J et al..  2021.  Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.. Nat Genet. 53(3):294-303.
Wang H, Bennett DA, De Jager PL, Zhang Q-Y, Zhang H-Y.  2021.  Genome-wide epistasis analysis for Alzheimer's disease and implications for genetic risk prediction.. Alzheimers Res Ther. 13(1):55.
He Z, Liu L, Wang C, Le Guen Y, Lee J, Gogarten S, Lu F, Montgomery S, Tang H, Silverman EK et al..  2021.  Identification of putative causal loci in whole-genome sequencing data via knockoff statistics.. Nat Commun. 12(1):3152.
Baird DA, Liu JZ, Zheng J, Sieberts SK, Perumal T, Elsworth B, Richardson TG, Chen C-Y, Carrasquillo MM, Allen M et al..  2021.  Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.. PLoS Genet. 17(1):e1009224.
Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX, Cheng H, Fullard JF, Bendl J, Liu Y et al..  2021.  Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.. Nat Commun. 12(1):1610.
Kirola L, Budde JP, Wang F, Norton J, Morris JC, Cruchaga C, Fernández MVictoria.  2021.  Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population.. Acta Neuropathol. 141(4):623-624.
Kunkle BW, Schmidt M, Klein H-U, Naj AC, Hamilton-Nelson KL, Larson EB, Evans DA, De Jager PL, Crane PK, Buxbaum JD et al..  2021.  Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.. JAMA Neurol. 78(1):102-113.
Sariya S, Felsky D, Reyes-Dumeyer D, Lali R, Lantigua RA, Vardarajan B, Jimenez-Velazquez IZ, Haines JL, Shellenberg GD, Pericak-Vance MA et al..  2021.  Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.. Ann Neurol. 90(3):366-376.
Patel D, Zhang X, Farrell JJ, Lunetta KL, Farrer LA.  2021.  Set-Based Rare Variant Expression Quantitative Trait Loci in Blood and Brain from Alzheimer Disease Study Participants.. Genes (Basel). 12(3)
Amlie-Wolf A, Kuksa PP, Lee C-Y, Mlynarski E, Leung YYee, San Wang L-.  2021.  Using INFERNO to Infer the Molecular Mechanisms Underlying Noncoding Genetic Associations.. Methods Mol Biol. 2254:73-91.
2020
Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD.  2020.  Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.. JAMA Neurol. 77(7):849-862.
Peloso GM, Beiser AS, Satizabal CL, Xanthakis V, Vasan RS, Pase MP, DeStefano AL, Seshadri S.  2020.  Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study.. Neurology. 95(10):e1341-e1350.
Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, Yanek LR, Wen W, Gudnason VG, Dueker ND et al..  2020.  Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.. Stroke. 51(7):2111-2121.
Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J et al..  2020.  Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.. Nat Commun. 11(1):667.
Vance E, Murcia JDGonzalez, Miller JB, Staley L, Crane PK, Mukherjee S, Kauwe JSK.  2020.  Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.. Neurobiol Aging. 89:142.e9-142.e12.
Neuner SM, Tcw J, Goate AM.  2020.  Genetic architecture of Alzheimer's disease.. Neurobiol Dis. 143:104976.
Guerreiro R, Gibbons E, Tábuas-Pereira M, Kun-Rodrigues C, Santo GC, Bras J.  2020.  Genetic architecture of common non-Alzheimer's disease dementias.. Neurobiol Dis. 142:104946.
Andrews SJ, Fulton-Howard B, Goate A.  2020.  Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.. Lancet Neurol. 19(4):326-335.
Strickland SL, Reddy JS, Allen M, N'songo A, Burgess JD, Corda MM, Ballard T, Wang X, Carrasquillo MM, Biernacka JM et al..  2020.  MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.. Alzheimers Dement. 16(7):983-1002.
Tang Z-Z, Sliwoski GR, Chen G, Jin B, Bush WS, Li B, Capra JA.  2020.  PSCAN: Spatial scan tests guided by protein structures improve complex disease gene discovery and signal variant detection.. Genome Biol. 21(1):217.
Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, Glaab E, Bobbili DReddy, Antony P, Koegelsberger S et al..  2020.  A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease.. Mol Psychiatry. 25(3):629-639.
Zhang Q, Sidorenko J, Couvy-Duchesne B, Marioni RE, Wright MJ, Goate AM, Marcora E, Huang K-L, Porter T, Laws SM et al..  2020.  Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture.. Nat Commun. 11(1):4799.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer